Literature DB >> 30363551

Holoprosencephaly-Associated Hyperkinesia.

Marisela E Dy1,2,3, Nathaniel A Chuang4, Jennifer Friedman2,3.   

Abstract

Entities:  

Keywords:  holoprosencephaly; hyperkinetic movements; trihexyphenidyl

Year:  2015        PMID： 30363551      PMCID： PMC6178715          DOI： 10.1002/mdc3.12176

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  10 in total

1.  The middle interhemispheric variant of holoprosencephaly.

Authors:  Erin M Simon; Robert F Hevner; Joseph D Pinter; Nancy J Clegg; Mauricio Delgado; Stephen L Kinsman; Jin S Hahn; A James Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 2.  Evaluation and management of children with holoprosencephaly.

Authors:  Jin S Hahn; Lauren L Plawner
Journal:  Pediatr Neurol       Date:  2004-08       Impact factor: 3.372

3.  Generalized chorea in an infant with semilobar holoprosencephaly.

Authors:  E D Louis; T Lynch; A L Cargan; S Fahn
Journal:  Pediatr Neurol       Date:  1995-11       Impact factor: 3.372

4.  Choreiform movements induced by anticholinergic therapy.

Authors:  R W Warne; S S Gubbay
Journal:  Med J Aust       Date:  1979-05-19       Impact factor: 7.738

5.  Neuroanatomy of holoprosencephaly as predictor of function: beyond the face predicting the brain.

Authors:  L L Plawner; M R Delgado; V S Miller; E B Levey; S L Kinsman; A J Barkovich; E M Simon; N J Clegg; V T Sweet; E E Stashinko; J S Hahn
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

6.  Assessment of the deep gray nuclei in holoprosencephaly.

Authors:  E M Simon; R Hevner; J D Pinter; N J Clegg; V S Miller; S L Kinsman; J S Hahn; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2000 Nov-Dec       Impact factor: 3.825

7.  Anticholinergic-induced chorea in the treatment of focal dystonia.

Authors:  M Nomoto; P D Thompson; M P Sheehy; N P Quinn; C D Marsden
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338

8.  Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy.

Authors:  Terence D Sanger; Amy Bastian; Jan Brunstrom; Diane Damiano; Mauricio Delgado; Leon Dure; Deborah Gaebler-Spira; Alec Hoon; Jonathan W Mink; Sara Sherman-Levine; Leah J Welty
Journal:  J Child Neurol       Date:  2007-05       Impact factor: 1.987

Review 9.  Management of children with holoprosencephaly.

Authors:  Eric B Levey; Elaine Stashinko; Nancy J Clegg; Mauricio R Delgado
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-02-15       Impact factor: 3.908

Review 10.  Holoprosencephaly.

Authors:  Christèle Dubourg; Claude Bendavid; Laurent Pasquier; Catherine Henry; Sylvie Odent; Véronique David
Journal:  Orphanet J Rare Dis       Date:  2007-02-02       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.